174 related articles for article (PubMed ID: 15793787)
21. Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease.
Haas M; Yilmaz N; Schmidt A; Neyer U; Arneitz K; Stummvoll HK; Wallner M; Auinger M; Arias I; Schneider B; Mayer G
Kidney Blood Press Res; 1998; 21(1):66-9. PubMed ID: 9661139
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE.
Uhm WS; Lee HS; Chung YH; Kim TH; Bae SC; Joo KB; Kim TY; Yoo DH
Lupus; 2002; 11(4):227-33. PubMed ID: 12043886
[TBL] [Abstract][Full Text] [Related]
23. Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.
Park HC; Choi HY; Kim BS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
Kidney Blood Press Res; 2006; 29(4):216-24. PubMed ID: 16960460
[TBL] [Abstract][Full Text] [Related]
24. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the drug treatment in patients with chronic heart failure].
Huang WY; Sun M; Zhou HY; Pei ZF; Yang TL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):686-9. PubMed ID: 16114558
[TBL] [Abstract][Full Text] [Related]
25. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
[TBL] [Abstract][Full Text] [Related]
26. Distribution of angiotensin converting enzyme gene polymorphism among Northern Hans, Dahurs, and Ewenks.
Zhang YM; Zhang LY; Wang KQ; Ge JB
Acta Pharmacol Sin; 2001 Aug; 22(8):747-50. PubMed ID: 11749850
[TBL] [Abstract][Full Text] [Related]
27. Interaction between angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on survival in hemodialyzed patients.
Kiss I; Ambrus C; Kulcsár I; Szegedi J; Kerkovits L; Tislér A; Kiss Z;
Medicine (Baltimore); 2014 Dec; 93(28):e315. PubMed ID: 25526485
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
Vegter S; Perna A; Hiddema W; Ruggenenti P; Remuzzi G; Navis G; Postma MJ
Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696
[TBL] [Abstract][Full Text] [Related]
29. Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients.
Huang W; Xie C; Zhou H; Yang T; Sun M
Eur J Heart Fail; 2004 Jan; 6(1):23-7. PubMed ID: 15012915
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis.
Woo KT; Lau YK; Chan CM; Wong KS
Ann Acad Med Singap; 2008 May; 37(5):372-6. PubMed ID: 18536822
[TBL] [Abstract][Full Text] [Related]
31. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype.
Cicoira M; Zanolla L; Rossi A; Golia G; Franceschini L; Cabrini G; Bonizzato A; Graziani M; Anker SD; Coats AJ; Zardini P
J Am Coll Cardiol; 2001 Jun; 37(7):1808-12. PubMed ID: 11401115
[TBL] [Abstract][Full Text] [Related]
32. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
[TBL] [Abstract][Full Text] [Related]
33. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
34. [Association of angiotensin I-converting enzyme gene polymorphism with ACE and PAI-1 levels in Guangdong Chinese Han patients with essential hypertension].
Zhang YL; Zhou SX; Lei J; Zhang JM
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1681-4. PubMed ID: 18024289
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Turkish patients.
Simsek S; Tekes S; Turkyilmaz A; Tuzcu AK; Kılıc F; Culcu NN; Isık B; Akbas H
J Endocrinol Invest; 2013 Nov; 36(10):860-3. PubMed ID: 23685945
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy.
Galão AO; de Souza LH; da Costa BE; Scheibe RM; Poli de Figueiredo CE
Am J Obstet Gynecol; 2004 Sep; 191(3):821-4. PubMed ID: 15467548
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism.
So WY; Ma RC; Ozaki R; Tong PC; Ng MC; Ho CS; Lam CW; Chow CC; Chan WB; Kong AP; Chan JC
Kidney Int; 2006 Apr; 69(8):1438-43. PubMed ID: 16395257
[TBL] [Abstract][Full Text] [Related]
38. Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors.
Chen YY; Liu D; Zhang P; Zhong JC; Zhang CJ; Wu SL; Zhang YQ; Liu GZ; He M; Jin LJ; Yu HM
J Hum Hypertens; 2016 Dec; 30(12):766-771. PubMed ID: 27121444
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism is not a risk factor for hypertension in SLE nephritis.
Negi VS; Devaraju P; Gulati R
Clin Rheumatol; 2015 Sep; 34(9):1545-9. PubMed ID: 25957879
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients.
Tronvik E; Stovner LJ; Bovim G; White LR; Gladwin AJ; Owen K; Schrader H
BMC Neurol; 2008 Mar; 8():4. PubMed ID: 18366776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
